Page last updated: 2024-08-24

ursolic acid and Acute Myelogenous Leukemia

ursolic acid has been researched along with Acute Myelogenous Leukemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, H; Chen, Y; Gao, Y; Hu, J; Li, C; Zheng, Y1
Andam, CP; Barth, BM; Belknap, KC; Brown, TJ; Claxton, DF; Dwyer, GK; Kircher, TA; McGill, CM; Ondrasik, RM; Quinlan, DJ; Tomco, PL1
Fang, Q; Hu, X; Li, Y; Ma, D; Sun, J; Wang, J; Wang, P; Zhang, Y; Zhou, S1
He, YM; Shen, J; Wang, JS; Xi, T; Xing, YY; Zhang, T1

Other Studies

4 other study(ies) available for ursolic acid and Acute Myelogenous Leukemia

ArticleYear
Discovery of FZU-03,010 as a self-assembling anticancer amphiphile for acute myeloid leukemia.
    Bioorganic & medicinal chemistry letters, 2017, 02-15, Volume: 27, Issue:4

    Topics: Antineoplastic Agents; Drug Discovery; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Piperazines; Triterpenes

2017
Therapeutic effect of Northern Labrador tea extracts for acute myeloid leukemia.
    Phytotherapy research : PTR, 2018, Volume: 32, Issue:8

    Topics: Animals; Cell Line, Tumor; Humans; Ledum; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred C57BL; Plant Extracts; Plants, Medicinal; Triterpenes; Ursolic Acid

2018
Crucial role of heme oxygenase-1 in the sensitivity of acute myeloid leukemia cell line Kasumi-1 to ursolic acid.
    Anti-cancer drugs, 2014, Volume: 25, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytarabine; Drug Resistance, Neoplasm; Drug Synergism; Heme Oxygenase-1; Humans; Leukemia, Myeloid, Acute; Mice; Neoplasm Transplantation; Protoporphyrins; Triterpenes; Ursolic Acid

2014
Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation.
    Anti-cancer drugs, 2011, Volume: 22, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Flavonoids; HCT116 Cells; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Phosphorylation; Proto-Oncogene Proteins c-myc; Triterpenes; U937 Cells; Up-Regulation; Ursolic Acid

2011